Combination of radiation and razoxane (ICRF 159) in vivo
- 28 February 1978
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 4 (1-2) , 109-113
- https://doi.org/10.1016/0360-3016(78)90124-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159The British Journal of Radiology, 1976
- ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; RazoxaneCancer Treatment Reviews, 1976
- An improved apparatus for the measurement of oxygen concentrationPhysics in Medicine & Biology, 1975
- Strahlentherapie und ICRF 159 (NSC 129943) in der Behandlung inoperabler WeichteilsarkomeDeutsche Medizinische Wochenschrift (1946), 1974
- Synergism of ICRF 159 and radiotherapy in treatment of experimental tumorsCancer, 1974
- Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159Cancer, 1974
- Cumulative Cytostatic Effect of ICRF 159Nature, 1974
- Combined treatment of the Walker tumour with radiotherapy and ICRF 159Zeitschrift für Krebsforschung und Klinische Onkologie, 1974
- Cell Proliferation and the Action of Cytotoxic Agents on Haemopoietic TissueBritish Journal of Haematology, 1972
- Metastases and the Normalization of Tumour Blood Vessels by ICRF 159: A New Type of Drug ActionBMJ, 1972